Genes linked to MS severity

17 December 2007

New research has found an association between certain genes and the severity of multiple sclerosis, according to a study led by George Ebers, chair of clinical neurology at the UK's Wellcome Trust Centre for Human Genetics, which will be published in the journal Proceedings of the National Academy of Sciences.

The study involved comparing genes from people with severe MS who used wheelchairs within five years of being diagnosed and those who had no disability 20 years after diagnosis. Dr Ebers found that a particular version of a gene called HLA-DRB1*01 was rare in people with severe MS and suggests it plays a protective role against the more severe progressive course that some can experience with this disabling neurological disorder.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight